Semaglutide
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Ozempic-like drugs may improve kidney disease outcomes: study
Semaglutide and Ozempic-like drugs may improve kidney disease outcomes Wed 3 Jun 2026 at 5:00am In short: New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they have heart disease or heart failure. This builds on previous research which found the drug had "consistent benefits" preventing heart attacks, strokes, and death due to cardiovascular causes in those with chronic...
Weight loss jab users warned not to ignore 1 symptom affecting the eyes
Weight loss jab users warned not to ignore 1 symptom affecting the eyes Health officials have issued a warning to weight loss jab users after a rare eye condition was linked to a popular medication used by thousands Millions of people use weight loss and diabetes jabs every year, but health officials are warning patients to be alert to one potentially serious symptom that could affect their eyesight. The alert concerns medicines containing semaglutide, including Wegovy, Ozempic and Rybelsus....
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and...
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
GLP-1 overdoses increase at an alarming rate as weight loss drugs become easier to buy online
Close-up image of an individual administering a semaglutide injection into their abdomen for weight loss and obesity management. A personal moment showcasing modern medical solutions for health improvement.
Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that's risky
Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that's risky The same drug that is helping patients manage diabetes and reduce their risk of serious complications from chronic conditions is also being discussed as a beauty hack by people hoping to lose a few kilograms. Experts say more education and awareness are needed.
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk Popular GLP-1 weight-loss drugs may have an unexpected bonus: a significantly lower risk of breast cancer. - Date: - June 6, 2026 - Source: - University of Pennsylvania School of Medicine - Summary: - A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit. A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over the...
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Pfizer and Amgen are developing monthly GLP-1 shots — a departure from injections like Wegovy and Zepbound, which are taken weekly.
'Call 111' now if you notice this weight loss jab side effect
'Call 111' now if you notice this weight loss jab side effect Around one in 10 people experience side effects from weight loss medications Brits who use weight loss jabs have been urged to “call 111” if they experience a potentially dangerous symptom. This could indicate a serious side effect affecting around one in 100 patients. Weight loss medications, also referred to as GLP-1 inhibitors, work by mimicking GLP-1 (glucagon-like peptide-1), a hormone naturally produced in the gut that plays...